PTC Therapeutics (PTCT) Competitor Comparison
We are evaluating the key criteria listed to compare PTC Therapeutics (PTCT) against its competitors in the Biotechnology industry.
Market Capitalization
78 / 368Gross Profits
114 / 278Total Revenue
19 / 300EBITDA
304 / 337Free Cashflow
313 / 352Quick Ratio
328 / 357Earnings per Share
321 / 359Dividend yield
0 / 6Total Cash
115 / 358Performance 3 years
90 / 368Performance 5 years
130 / 368Performance 10 years
103 / 368Linearity 3 years
7 / 368Linearity 5 years
2 / 368Linearity 10 years
9 / 368Total Rank
240 / 368Dividend Rank
250 / 368Valuation Rank
127 / 368Piotroski Rank
99 / 368Muliplier Rank
25 / 368Gross Profits - PTCT ranking 114 / 278
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.